“…No trials were available for inclusion in the review that support the sustainability of the benefits of duloxetine (Mariappan, Alhasso, Crant, & N'Dow, 2009). Duloxetine is not FDA-approved in the United States due to adverse events, including liver toxicity and suicidal ideations (Verghese & Latthe, 2013).…”